Soft Tissue Head and Neck

Primary Site Histology Behavior
C000-C148, C150, C153, C158, C300-C301, C310-C329, C739, C750, C754-C759 8710-8714, 8800-8803, 8810-8905, 8912, 8921, 8932-8934, 8963-8964, 8990, 8992, 9010-9016, 9030-9043, 9045, 9121-9138, 9141-9230, 9240-9262, 9271-9290, 9320-9330, 9364-9373, 9540, 9542-9580, 9582 <Any value>
C470, C490 8000-8803, 8810-8905, 8912, 8921, 8932-8934, 8940-8990, 8992, 9000-9016, 9030-9043, 9045-9111, 9121-9138, 9141-9230, 9240-9580, 9582 <Any value>
C722, C724-C725, C751-C753 8711, 8800-8802, 8810-8811, 8815, 8825, 8832-8833, 8840, 8850, 8852, 8854, 8858-8859, 8890, 8901, 8912, 9040-9041, 9043, 9133, 9136, 9180, 9222, 9251, 9364, 9366-9368, 9540, 9542, 9561, 9580 3

Notes

**See table above for primary sites and histologies for this schema** **Note 1:** **Sources used in the development of this schema** * SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf) * SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/) * Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx * Chapter 40 *Soft Tissue Sarcoma of the Head and Neck*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois. **Note 2:** **For C471-C472, C476, C478-C479, C491-C492, C496, C498-C499 ONLY see the following schemas for the listed histologies** * **GIST**: 8935-8936 * **Kaposi Sarcoma**: 9140 * **Mycosis Fungoides**: 9700-9701 * **Soft Tissue Rare**: 8804-8806, 8910, 8920, 8930-8931, 8991, 9020, 9044, 9120, 9231, 9581

Data Items

Name Default Value Used in Derivation NAACCR Item Required By Metadata
Year of Diagnosis No NAACCR #390
dateOfDiagnosis 		None
Primary Site Yes NAACCR #400
primarySite 		None
Histology Yes NAACCR #522
histologicTypeIcdO3 		None
Behavior Yes NAACCR #523
behaviorCodeIcdO3 		None
Type of Reporting Source No NAACCR #500
typeOfReportingSource 		None
Tumor Size Clinical No NAACCR #752
tumorSizeClinical 		None
Tumor Size Pathological No NAACCR #754
tumorSizePathologic 		None
Tumor Size Summary 999 No NAACCR #756
tumorSizeSummary 		None
Regional Nodes Positive 99 No NAACCR #820
regionalNodesPositive 		None
Regional Nodes Examined 99 No NAACCR #830
regionalNodesExamined 		None
EOD Primary Tumor 999 Yes NAACCR #772
eodPrimaryTumor 		None
EOD Regional Nodes 999 Yes NAACCR #774
eodRegionalNodes 		None
EOD Mets 00 Yes NAACCR #776
eodMets 		None
SS2018 No NAACCR #764
summaryStage2018 		None
Grade Clinical 9 Yes NAACCR #3843
gradeClinical 		All SSDI
Grade Pathological 9 Yes NAACCR #3844
gradePathological 		All SSDI
Grade Post Therapy Clin (yc) No NAACCR #1068
gradePostTherapyClin 		COC
NPCR
SEER		 SSDI
Grade Post Therapy Path (yp) No NAACCR #3845
gradePostTherapy 		CCCR/Canada
COC
NPCR
SEER		 SSDI
Bone Invasion 8 No NAACCR #3815
boneInvasion 		COC
SEER 2018–2023
SEER (RC) 2024–		 SSDI
Neoadjuvant Therapy 9 No NAACCR #1632
neoadjuvantTherapy 		SEER 2021– SSDI 2021–
Neoadjuvant Therapy – Clinical Response 99 No NAACCR #1633
neoadjuvTherapyClinicalResponse 		SEER 2021– SSDI 2021–
Neoadjuvant Therapy – Treatment Effect 9 No NAACCR #1634
neoadjuvTherapyTreatmentEffect 		SEER 2021– SSDI 2021–

Initial Context

Staging Methods

Expand All | Collapse All

Summary Stage 2018

Start

  2. Derived Summary Grade
  3. derived_summary_grade

Next Step

  2. EOD Primary Tumor
  3. ss2018_t

Next Step

  2. EOD Regional Nodes
  3. ss2018_n

Next Step

  2. EOD Mets
  3. ss2018_m

Next Step

  2. Summary Stage
  3. ss2018_derived

End

Outputs

Name Default Value Description NAACCR Item Metadata
Schema ID 00400 NAACCR #3800
schemaId 		None
Derived Version {{ctx_alg_version}} None None
Derived Summary Stage 2018 9 NAACCR #762
derivedSummaryStage2018 		None
Derived Summary Grade 2018 <BLANK> NAACCR #1975
derivedSummaryGrade2018 		None